Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Dual 5-HT reuptake inhibitors/5-HT1A antagonists with potential as antidepressants

Aug. 26, 1998

Pagoclone reduces frequency of panic attacks in patients with panic disorder

Aug. 26, 1998

Disappointing results obtained in phase II/III trial of LU-25-109T

Aug. 25, 1998

Bristol-Myers Squibb discovers novel maxi-K channel openers

Aug. 25, 1998

Novel cysteine protease inhibitors discussed by BASF

Aug. 24, 1998

HemispheRx announces first regulatory filing for CFS/ME treatment agent

Aug. 21, 1998

LY-341495 proves to be a potent tool in the study of metabotropic glutamate receptor function

Aug. 21, 1998

First application of Medtronic's neurostimulator in two patients with Parkinson's disease

Aug. 21, 1998

Yoshitomi claims safe and effective new antipsychotic agents

Aug. 21, 1998

Vertex solves 3D structure of JNK3, an enzyme implicated in epilepsy and stroke

Aug. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...